超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

江蘇正大天晴藥業股份有限公司是集科研、生產和銷售為一體的大型醫藥企業，是國內最大的肝健康藥物研發和生產基地之一。江蘇正大天晴藥業是國家重點高新技術企業、國家火炬計劃連云港新醫藥產業基地重點骨干企業、中國制藥工業百強企業。

江蘇正大天晴藥業產品治療涉及肝病、腫瘤、糖尿病、呼吸、心腦血管、抗感染、消化、神經等多個疾病領域，特別是在肝病藥物研究領域具備獨特的優勢。主要產品有潤眾（恩替卡韋分散片）、名正（阿德福韋酯膠囊）、甘利欣（甘草酸二銨注射液及其膠囊）、天晴甘美（異甘草酸鎂注射液）、天晴復欣（苦參素葡萄糖注射液）、天晴甘平（甘草酸二銨腸溶膠囊）、天晴依泰（唑來膦酸注射液）等。“天晴甘美”、“天晴甘平”、“名正”先后獲得中國國際專利博覽會金獎，“天晴甘美”獲得具有中國專利奧斯卡之稱的“中國專利金獎”。

正大天晴藥物研究院分為南京研發中心和連云港研發中心，擁有國家級博士后科研工作站、江蘇省新型肝病藥物工程技術研究中心兩個掛牌單位，中國工程院院士、著名肝病專家莊輝先生擔任江蘇省新型肝病藥物工程技術研究中心專家委員會主任。正大天晴藥物研究院的建立，使正大天晴已具備國內先進水平的研發創新平臺。未來的正大天晴藥物研究院將形成1院5所的結構，包括已經建成的南京開發所，連云港優化所，和將要建立的上海創新所、北京創新所和美國信息所。

隨著正大天晴創新能力的不斷加強，自主創新成果碩果累累，企業的核心競爭力不斷提升。目前正大天晴在甘草制劑領域的研究已取得國內第一、世界領先地位，成為國內在此領域研究歷史最長、獲得成果最多的企業。“十五”以來，公司先后承擔了40多項國家、省級重大科技項目，其中“863”計劃3項，“十一五”“重大新藥創制”科技重大專項3項，省科技成果轉化專項資金項目3項，培育國家重點新產品6個，江蘇省高新技術產品15個。江蘇正大天晴藥業目前擁有5家全資子公司和4家控股子公司，在連云港建有三個生產基地，總占地面積800余畝。其中：位于連云港市區東側的廠區，占地140畝，分別建有大、小容量注射劑、固體制劑、中藥提取、粉針劑等生產車間；位于連云港經濟技術開發區大浦工業園區的原料藥基地——潤眾制藥，占地200多畝，主導產品為恩替卡韋、異甘草酸鎂、甘草酸二銨、阿德福韋酯、羥乙基淀粉等20余個品種的原料藥和中間體；位于連云港海州經濟開發區的海州制劑新區規劃面積480畝，總投資10億元，車間均按照歐盟和美國FDA標準設計建設，部分產品將出口歐美等主流藥品市場。公司始終堅持走質量效益發展之路，將質量管理作為企業生產管理的重中之重，堅持“把產品質量視為企業的生命之本，把客戶滿意作為企業的不懈追求”的質量方針，公司分別于2000年、2004年、2007年度獲得“江蘇省質量管理獎”。為了保證藥品質量，正大天晴藥業在國家法定標準基礎上，建立了一套遠高于國家法定標準的企業內控標準，還致力于采用國際標準和國外先進標準。

未來的江蘇正大天晴藥業將繼續秉承創新理念，以“健康人類，共創美好未來”為宗旨，致力于藥物創新，努力開拓國際市場，把公司建立成為“以專利藥為龍頭的產品鏈和產品結構，以研發為驅動力、營銷為中心，集生產制造于一體的現代制藥企業”。
 

Brief introduction for Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd.

Jiangsu Chia-tai Tianqing Pharmaceutical Co., Ltd. is a large pharmaceutical manufacturer which integrates research, production and sales as a whole. It is also one of the largest researching and manufacturing bases and state key high and new technology enterprises, major enterprises of Lianyungang new medical industrial base of state torch plan, and one of the top 100 powers of China pharmaceutical industry.

Jiangsu Chia-tai Tianqing Pharmaceutical Company’s products involves in hepatitis, cancer, cardio-vascular, anti-virus, digestion, respiratory, diabetes etc., particularly possesses advantages in hepatopathy fields. Its products like runzhong, adefovir, ganlixin, ganmei, tianqing yitai, ganping, mingzheng won golden award of China International Patent Right Fair. Tianqing ganmei won China patent golden award, which is honorably named Chinese Oscar reputation.

The research institute has Lianyungang and Nanjing branches with two boards that postal doctoral program and Jiangsu engineering technology research center for new type hepatopathy medicine hanged on. Mr. Zhuang Hui, a outstanding scientist who also is academician of China Academy, assumes the office of director of Experts Commission for Jiangsu Engineering Technology Research Center for New Type Hepatopathy Medicines. The building of CTTQ’s institute equips itself a platform of domestic advanced innovation and research. CTTQ’s medicines research institute will be composed by Nanjing and Lianyungang branches which already put in practical work, and Shanghai Renovation Branch, Beijing Developing Branch, and American Information Branch.

The company’s core competitive ability is strengthened as it’s renovation ability level is upgraded and fruitful achievements achieved. Now CTTQ’s licorice extracts research is leading both at home and abroad not only for the longest history but also the most fruitful achievements. Since the period of 10th-five years plan, the company assumed 40 state and province major science and technology items, including 3 items of 863 plan, 3 items of important new medicine renovation of 11th-five years plan, 3 items of provincial science and technology application and transfer special programs. It explores 6 state key new products and 15 new high technology products.

CTTQ has 5 complete capitalized-controlled sub-companies, 4 majority capitalized-controlled sub-companies and 3 manufacture bases with a covering area of 55 hectares. Located in the east area of Lianyungang, the general plan with large volume and small volume injection, solid prescription products, traditional Chinese herbal extract workshops, covers an area of 140 mu. Located in Lianyungang economic and technology developing zone, Rain join pharmacy, covering an area of 200 mu, is a bulk drug manufacture plant mainly dealing with more than 20 sorts of inter-media and raw materials such as aderfovir, enticuvir, licorice extracts, starch. With a total one billion CNY investment and an area of 200 mu, Haechow new prescription plant’s workshops was designed and constructed according with E.U. and FDA regulation. Some of its products will be sold afar in the oversea market like the U.S. and Europe.

The company always insists on the balance between quality and profits. It focuses great attention on quality control management which among enterprise management. The company keeps the principles that quality is the grass root of enterprise’s life and keeps seeking to satisfy the clients. It won the reward of Jiangsu quality management in 2000, 2004, and 2007. To insure the medicines’ quality, the company set up a new enterprise homely-controlled standard priority to state legal standard which it based on. It also devotes to international standard and advanced foreign standard.

Chia-tai Tianqing Pharmacy sets up Lianyungang chia-tai tianqing medical co., Ltd., which is specialized in professional academic promotion and sales for medicines in market. Leading by latest sales concepts, the sales company emphasizes greatly the academic promotion for medicines. Leading by market sales, and the company builds up modern medical sales system with a strong professional academic team.

Aiming at the principle of promoting people’s health, creating a paradise future, Jiangsu Chia-tai Tianqing Pharmacy will inherit the concept of innovation, devotes to medicine’s innovation and exploring international market, Being driven by patented medicines and sales , Chia-Tai Tianqing pharmacy will soon grow into a modern pharmaceutical manufacturer which integrates manufacture and research as a whole.